Found: 21
Select item for more details and to access through your institution.
Human seasonal coronavirus neutralization and COVID‐19 severity.
- Published in:
- Journal of Medical Virology, 2022, v. 94, n. 10, p. 4820, doi. 10.1002/jmv.27937
- By:
- Publication type:
- Article
Influenza A (N1-N9) and Influenza B (B/Victoria and B/Yamagata) Neuraminidase Pseudotypes as Tools for Pandemic Preparedness and Improved Influenza Vaccine Design.
- Published in:
- Vaccines, 2022, v. 10, n. 9, p. 1520, doi. 10.3390/vaccines10091520
- By:
- Publication type:
- Article
Stepwise Conformational Stabilization of a HIV-1 Clade C Consensus Envelope Trimer Immunogen Impacts the Profile of Vaccine-Induced Antibody Responses.
- Published in:
- Vaccines, 2021, v. 9, n. 7, p. 750, doi. 10.3390/vaccines9070750
- By:
- Publication type:
- Article
Exploiting Pan Influenza A and Pan Influenza B Pseudotype Libraries for Efficient Vaccine Antigen Selection.
- Published in:
- Vaccines, 2021, v. 9, n. 7, p. 741, doi. 10.3390/vaccines9070741
- By:
- Publication type:
- Article
Correlation of Influenza B Haemagglutination Inhibiton, Single-Radial Haemolysis and Pseudotype-Based Microneutralisation Assays for Immunogenicity Testing of Seasonal Vaccines.
- Published in:
- Vaccines, 2021, v. 9, n. 2, p. 100, doi. 10.3390/vaccines9020100
- By:
- Publication type:
- Article
Neutralisation Hierarchy of SARS-CoV-2 Variants of Concern Using Standardised, Quantitative Neutralisation Assays Reveals a Correlation With Disease Severity; Towards Deciphering Protective Antibody Thresholds.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.773982
- By:
- Publication type:
- Article
AutoPlate: Rapid Dose-Response Curve Analysis for Biological Assays.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2021.681636
- By:
- Publication type:
- Article
Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 Cases.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.748291
- By:
- Publication type:
- Article
Stalking influenza by vaccination with pre-fusion headless HA mini-stem.
- Published in:
- Scientific Reports, 2016, p. 22666, doi. 10.1038/srep22666
- By:
- Publication type:
- Article
Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02312
- By:
- Publication type:
- Article
Tetherin antagonism by SARS‐CoV‐2 ORF3a and spike protein enhances virus release.
- Published in:
- EMBO Reports, 2023, v. 24, n. 12, p. 1, doi. 10.15252/embr.202357224
- By:
- Publication type:
- Article
Editorial: Novel approaches to prevention, diagnosis, and treatment of bacterial and viral infections of clinical relevance.
- Published in:
- Frontiers in Microbiology, 2023, p. 1, doi. 10.3389/fmicb.2023.1192435
- By:
- Publication type:
- Article
Computationally designed Spike antigens induce neutralising responses against the breadth of SARS-COV-2 variants.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00950-9
- By:
- Publication type:
- Article
Development of Lentiviral Vectors Pseudotyped With Influenza B Hemagglutinins: Application in Vaccine Immunogenicity, mAb Potency, and Sero-Surveillance Studies.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.661379
- By:
- Publication type:
- Article
Coronavirus Pseudotypes for All Circulating Human Coronaviruses for Quantification of Cross-Neutralizing Antibody Responses.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 8, p. 1579, doi. 10.3390/v13081579
- By:
- Publication type:
- Article
Nanobodies mapped to cross-reactive and divergent epitopes on A(H7N9) influenza hemagglutinin using yeast display.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-82356-4
- By:
- Publication type:
- Article
Cross-Reactive and Lineage-Specific Single Domain Antibodies against Influenza B Hemagglutinin.
- Published in:
- Antibodies (2073-4468), 2019, v. 8, n. 1, p. 14, doi. 10.3390/antib8010014
- By:
- Publication type:
- Article
Development of a Clinical MALDI-ToF Mass Spectrometry Assay for SARS-CoV-2: Rational Design and Multi-Disciplinary Team Work.
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 10, p. 746, doi. 10.3390/diagnostics10100746
- By:
- Publication type:
- Article
A naturally protective epitope of limited variability as an influenza vaccine target.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-06228-8
- By:
- Publication type:
- Article
Inhibition of the Lectin Pathway of Complement Activation Reduces Acute Respiratory Distress Syndrome Severity in a Mouse Model of SARS-CoV-2 Infection.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, n. 3, p. 680, doi. 10.1093/infdis/jiad462
- By:
- Publication type:
- Article
Pseudotype-based neutralization assays for influenza: a systematic analysis.
- Published in:
- Frontiers in Immunology, 2015, v. 6, p. 1, doi. 10.3389/fimmu.2015.00161
- By:
- Publication type:
- Article